The proxisome proliferator-activated receptor subtype (PPAR) is a multi-functional ligand-activated transcription factor. In addition to the well recognized metabolic action, PPAR exerts a profound influence on fluid metabolism and blood pressure (Bp) control through a complex mechanism involving regulation of renal sodium transport as well as vascular function. Previous studies employing mice with conditional deletion of PPAR in the collecting duct (CD) document a sodium-retaining function of PPAR in the distal nephron that underlies fluid retention and body weight gains associated with thiazolidinediones (TZDs). Further analysis of the KO mice on a low sodium diet reveals new evidence for a physiological function of CD PPAR in regulation of sodium balance and Bp. We propose to investigate specific targets, endogenous ligands and regulatory mechanisms of CD PPAR in the setting of sodium depletion. In particular, we will determine whether the recently discovered endogenous PPAR ligands which are nitrated fatty acids (NO2-FA), including LNO2 and OA-NO2, may play a role in regulation of CD function. Additionally, we will investigate the possible pathological role of CD PPAR in obesity-induced hypertension by testing the hypothesis that CD PPAR may serve as a link between energy metabolism and renal sodium excretion. To resolve the paradox that the activation of CD PPAR leads to fluid retention but is not associated with hypertension, we propose to investigate the potential anti-hypertensive and vasculoprotective functions of PPAR using mice with conditional deletion of PPAR in endothelial cells (EC PPAR KO) and vascular smooth muscle cells (SM PPAR KO). We propose the following three aims: 1) to investigate the role of NO2-FA/PPAR in regulation of renal sodium transport, 2) to investigate the role of NO2-FA/PPAR in regulation of sodium excretion during changing energy balance, and 3) to investigate the vascular function of NO2-FA/PPAR. New information provided by this proposal is expected to offer new insights into the integrative role of NO2-FA/PPAR in the control of renal and vascular functions.

Public Health Relevance

The prevalence of overweight and obesity has dramatically increased during the past 2 decades with 65% of the United States adults being overweight and 31% of adult being obese. Obesity related insulin resistance and hypertension are a major risk factor for cardiovascular diseases. The PPAR activators thiazolidinediones (TZDs) are highly effective for control of type 2 diabetes and also exhibit beneficial effects on cardiovascular disease. The current proposal is expected to provide new information for required for development of more effective therapies for the human disease.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Cellular and Molecular Biology of the Kidney Study Section (CMBK)
Program Officer
Ketchum, Christian J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Internal Medicine/Medicine
Schools of Medicine
Salt Lake City
United States
Zip Code
Jia, Zhanjun; Sun, Ying; Liu, Shanshan et al. (2014) COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes. PLoS One 9:e93182
Jia, Zhanjun; Liu, Gang; Sun, Ying et al. (2013) mPGES-1-derived PGE2 mediates dehydration natriuresis. Am J Physiol Renal Physiol 304:F214-21
Zhou, Li; Liu, Gang; Jia, Zhanjun et al. (2013) Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters. Am J Physiol Renal Physiol 305:F1491-7
Jia, Zhanjun; Liu, Gang; Downton, Maicy et al. (2012) mPGES-1 deletion potentiates urine concentrating capability after water deprivation. Am J Physiol Renal Physiol 302:F1005-12
Jia, Zhanjun; Wang, Haiping; Yang, Tianxin (2012) Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction. Hypertension 59:122-8
Zhang, Aihua; Jia, Zhanjun; Wang, Ningning et al. (2011) Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int 80:51-60
Jia, Zhanjun; Wang, Ningning; Aoyagi, Toshinori et al. (2011) Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int 79:77-88
Jia, Zhanjun; Aoyagi, Toshinori; Yang, Tianxin (2010) mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 55:539-46
Wang, Haiping; Liu, Haiying; Jia, Zhunjun et al. (2010) Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice. Am J Physiol Renal Physiol 298:F754-62
Jia, Zhanjun; Wang, Haiping; Yang, Tianxin (2009) Mice lacking mPGES-1 are resistant to lithium-induced polyuria. Am J Physiol Renal Physiol 297:F1689-96